Trading Signals: ANPC Stock Price Prediction and Forecast (Thu. Jan. 30, 2020 - Fri. May. 13, 2022)(AnPac Bio-Medical Science Co Ltd - ADR)
| ANPC latest price $6.1700 (-2.68%) ($6.1700 - $6.1700) on Wed. Mar. 24, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 8.71% (three month average) | RSI | 58 | Latest Price | $6.1700(-2.68%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ANPC declines -2.5% a day on average for past five trading days. | Weekly Trend | ANPC advances 0.7% a week on average for past two weeks. | Market Behavior | Growth stock sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support ANPC advance at 0% a week (0% probability) IGOV(17%) GLD(16%) VXX(13%) SLV(12%) GDX(10%) | Factors Impacting ANPC price | ANPC will decline at least -4.355% in a week (0% probabilities). ONLN(-14%) MCHI(-11%) XLY(-10%) FXI(-10%) VWO(-9%) | | | | | Relative Volatility | | | | Market Trend Strength | -4.355% (StdDev 8.71%) | Hourly BBV | -1.2 () | Intraday Trend | 0% | | | |
|
Resistance Level | $6.74 | 5 Day Moving Average | $6.69(-7.77%) | 10 Day Moving Average | $6.82(-9.53%) | 20 Day Moving Average | $6.74(-8.46%) | To recent high | -27.1% | To recent low | 16.6% | Market Cap | $53m | | | | Anpac Bio-Medical Science Co. Ltd., is a biotechnology company. It engages in marketing and selling multi-cancer screening and detection test that uses patented cancer differentiation analysis, or CDA, technology and proprietary cancer-detection device or CDA device. The company was founded by Chris Chang Yu and He Yu in 2010 and is headquartered in Lishui, China. |